Given that tau accumulations are commonly seen in other neurodegenerative diseases, including frontotemporal dementia, progressive supranuclear palsy, Pick's disease, and corticobasal syndrome, we expect that LM-021 may be promising for treating these tauopathies as well. Here, MAPT is linked to Classical progressive supranuclear palsy.